Liese Barbier

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Top Venues

Journal of medical Internet research

Journal of market access & health policy

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Evelien De Sutter, Liese Barbier, Pascal Borry, David Geerts, John P A Ioannidis, Isabelle Huys
Personalized and longitudinal electronic informed consent in clinical trials: How to move the needle? Digital health 10 (2024)
Zilke Claessens, Michiel Lammens, Liese Barbier, Isabelle Huys
Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative. Journal of market access & health policy 12 (3) (2024)
Evelien De Sutter, Liese Barbier, Pascal Borry, David Geerts, John P A Ioannidis, Isabelle Huys
Personalized and longitudinal electronic informed consent in clinical trials: How to move the needle? Digital health 10 (2024)
Zilke Claessens, Michiel Lammens, Liese Barbier, Isabelle Huys
Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative. Journal of market access & health policy 12 (3) (2024)
Evelien De Sutter, David Geerts, Koen Yskout, Stef Verreydt, Pascal Borry, Liese Barbier, Isabelle Huys
Testing and Practical Implementation of a User-Friendly Personalized and Long-Term Electronic Informed Consent Prototype in Clinical Research: Mixed Methods Study. Journal of medical Internet research 25 (2023)
Evelien De Sutter, David Geerts, Koen Yskout, Stef Verreydt, Pascal Borry, Liese Barbier, Isabelle Huys
Testing and Practical Implementation of a User-Friendly Personalized and Long-Term Electronic Informed Consent Prototype in Clinical Research: Mixed Methods Study. Journal of medical Internet research 25 (2023)
Evelien De Sutter, David Geerts, Koen Yskout, Stef Verreydt, Pascal Borry, Liese Barbier, Isabelle Huys
Testing and Practical Implementation of a User-Friendly Personalized and Long-Term Electronic Informed Consent Prototype in Clinical Research: Mixed Methods Study. Journal of medical Internet research 25 (2023)
Evelien De Sutter, David Geerts, Koen Yskout, Stef Verreydt, Pascal Borry, Liese Barbier, Isabelle Huys
Testing and Practical Implementation of a User-Friendly Personalized and Long-Term Electronic Informed Consent Prototype in Clinical Research: Mixed Methods Study. Journal of medical Internet research 25 (2023)
Evelien De Sutter, David Geerts, Koen Yskout, Stef Verreydt, Pascal Borry, Liese Barbier, Isabelle Huys
Testing and Practical Implementation of a User-Friendly Personalized and Long-Term Electronic Informed Consent Prototype in Clinical Research: Mixed Methods Study. Journal of medical Internet research 25 (2023)
Liese Barbier, Steven R A Simoens, Arnold G Vulto, Isabelle Huys
European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical Practice. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (6) (2021)
Liese Barbier, Steven R A Simoens, Caroline Soontjens, Barbara Claus, Arnold G Vulto, Isabelle Huys
Off-Patent Biologicals and Biosimilars Tendering in Europe-A Proposal towards More Sustainable Practices. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Liese Barbier, Steven R A Simoens, Arnold G Vulto, Isabelle Huys
European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and Adoption. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (6) (2021)
Liese Barbier, Yannick Vandenplas, Steven R A Simoens, Paul J Declerck, Arnold G Vulto, Isabelle Huys
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians. Journal of pharmaceutical policy and practice 14 (1) (2021)
Liese Barbier, Paul Declerck, Steven R A Simoens, Patrick Neven, Arnold G Vulto, Isabelle Huys
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars. British journal of cancer 121 (3) (2019)